Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Other Non-Current Liabilities (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $44.8 million as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities changed N/A to $44.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $44.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $44.8 million for FY2025, N/A changed from the prior year.
  • Other Non-Current Liabilities hit $44.8 million in Q4 2025 for Camp4 Therapeutics, up from $16.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $44.8 million in Q4 2025 to a low of $2000.0 in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $10.2 million across 3 years, with a median of $2000.0 in 2023.
  • Biggest YoY gain for Other Non-Current Liabilities was 836500.0% in 2025; the steepest drop was 836500.0% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then surged by 2237900.0% to $44.8 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CAMP at $44.8 million in Q4 2025, $16.7 million in Q3 2025, and $2000.0 in Q2 2025.